Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Mutations in certain receptors can cause diseases and offer new treatment options.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Certain genetic variants increase the risk of aggressive prostate cancer.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Skin cancer in sun-exposed areas is more likely to come back.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

Tangent screens help detect visual field defects from vigabatrin.

A mouse gene mutation increases the risk of skin cancer.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Some chemotherapy can cause permanent hair loss.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Some pediatric Ewing's sarcoma patients may experience permanent hair loss after chemotherapy, and treatments might not fully restore hair.

Wnt signaling is crucial for Hedgehog-driven skin tumor growth.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

A new skin cancer can develop where shingles once occurred.

Radiation increases cell death in hair follicles, but certain treatments can protect against this effect.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.